Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Best Practice & Research. Clinical Gastroenterology
|
December 16, 2023
Prognostic modelling in IBD
Peter Rimmer, Tariq Iqbal
Gastroenterology
|
December 23, 2025
The Gut Microbiome at the Onset of Inflammatory Bowel Disease: A Systematic Review and Unified Bioinformatic Synthesis
Peter Rimmer, Fan Zhang, Gregor Scott, et al.
Periodontology 2000
|
April 9, 2026
The role of neutrophils in the pathophysiology of inflammatory bowel diseases
Joao Paulo Steffens, Ekin Yay-Kus, Rafael Scaf de Molon, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)
|
March 13, 2026
The IBD-disk accurately assesses disability and psychological burden at IBD diagnosis and predicts adverse outcomes in both UC and Crohn's disease during the first year of treatment: a prospective observational cohort study
Peter Rimmer, Viorelia Stoica, Maryam Ibrahim, et al.
Frontline Gastroenterology
|
October 24, 2025
Optimising triage of urgent referrals for suspected IBD: results from the Birmingham IBD inception study
Peter Rimmer, Jonathan Cheesbrough, Jane Harris, et al.
BMJ Open
|
January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Sarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
Crohn'S & Colitis 360
|
June 15, 2026
A multicentered retrospective cohort study comparing JAK inhibitor therapies in moderate-to-severe ulcerative colitis
Aditi Kumar, Joshua Baxter, Peter Rimmer, et al.
Clinical Pharmacology and Therapeutics
|
February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE Experience
Julien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
Journal of Crohn'S & Colitis
|
December 14, 2024
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures
Mohammed Nabil Quraishi, Jonathan Cheesbrough, Peter Rimmer, et al.
Journal of Autoimmunity
|
March 24, 2024
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease
Anella Saviano, Anna Schettino, Nunzia Iaccarino, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Best Practice & Research. Clinical Gastroenterology
|
December 16, 2023
Prognostic modelling in IBD
Peter Rimmer, Tariq Iqbal
Gastroenterology
|
December 23, 2025
The Gut Microbiome at the Onset of Inflammatory Bowel Disease: A Systematic Review and Unified Bioinformatic Synthesis
Peter Rimmer, Fan Zhang, Gregor Scott, et al.
Periodontology 2000
|
April 9, 2026
The role of neutrophils in the pathophysiology of inflammatory bowel diseases
Joao Paulo Steffens, Ekin Yay-Kus, Rafael Scaf de Molon, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)
|
March 13, 2026
The IBD-disk accurately assesses disability and psychological burden at IBD diagnosis and predicts adverse outcomes in both UC and Crohn's disease during the first year of treatment: a prospective observational cohort study
Peter Rimmer, Viorelia Stoica, Maryam Ibrahim, et al.
Frontline Gastroenterology
|
October 24, 2025
Optimising triage of urgent referrals for suspected IBD: results from the Birmingham IBD inception study
Peter Rimmer, Jonathan Cheesbrough, Jane Harris, et al.
BMJ Open
|
January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Sarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
Crohn'S & Colitis 360
|
June 15, 2026
A multicentered retrospective cohort study comparing JAK inhibitor therapies in moderate-to-severe ulcerative colitis
Aditi Kumar, Joshua Baxter, Peter Rimmer, et al.
Clinical Pharmacology and Therapeutics
|
February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE Experience
Julien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
Journal of Crohn'S & Colitis
|
December 14, 2024
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures
Mohammed Nabil Quraishi, Jonathan Cheesbrough, Peter Rimmer, et al.
Journal of Autoimmunity
|
March 24, 2024
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease
Anella Saviano, Anna Schettino, Nunzia Iaccarino, et al.
Page
of 2